OpenAI Leads $15M Seed Round for Biosecurity Startup Red Queen Bio
Reuters reports that OpenAI has led a $15 million seed investment in Red Queen Bio, a startup focused on preventing the misuse of artificial intelligence in developing biological weapons. The company combines AI models with laboratory research to identify and counter emerging biosecurity risks.
Red Queen Bio was spun out of Helix Nano, an mRNA therapeutics company that has collaborated with OpenAI on assessing AI-related biological risks. The startup’s co-founder Hannu Rajaniemi said the goal is to ensure AI defenses evolve as quickly as potential threats.
The funding round also included contributions from Cerberus Ventures, Fifty Years, and Halcyon Futures. OpenAI stated that its chief compliance officer and unconflicted board members approved the investment, with executives holding prior stakes in Helix Nano recused from the process.
This marks OpenAI’s second recent investment in the biosecurity sector, following its participation in a funding round for Valthos, a New York-based startup developing AI-driven biosecurity software.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Defense AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Defense
Nov 19 Helsing scales back UK underwater drone plans after missing out on £90 million Royal Navy deal Nov 18 China's military is seeking Nvidia's most advanced chips, US congressional commission says Nov 18 Senator Mark Kelly proposes safety standards and independent examiners for frontier AI Nov 17 Pentagon makes AI a required part of training for its cybersecurity workforce Nov 17 AI models marked civilians as military targets in Vals tests, and calling it a game beat refusalsMore from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
OpenAI launches Daybreak Red Team and Defense Factory security agents
OpenAI Cuts Funding Target to $20 Billion at $1.25 Trillion Valuation, FT Reports
Bay emerges from stealth with $50 million to stop AI agents taking dangerous actions
Vero Security raises $11 million to enforce security policies on enterprise AI agents
OpenAI closes $11 billion at $1.25 trillion valuation
Daily AI Brief: the AI news that matters, in your inbox.